Which Treatment Offers Better Value For UK Patients?
Moving From Wegovy To Mounjaro: Understanding Monthly Cost Differences
When moving from Wegovy to Mounjaro, the most significant factor patients consider is ongoing monthly expense. Wegovy (semaglutide) follows a structured dose escalation over 16 weeks, starting at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), and £139.99 (1.7mg), before reaching the maintenance dose of 2.4mg at £209.99 monthly. Mounjaro (tirzepatide) operates on a different pricing model entirely, with its dual GIP and GLP-1 receptor agonist mechanism reflected in distinct cost structures. Both treatments represent significant monthly investments, but understanding the long-term financial commitment helps patients budget effectively.
The decision to move from Wegovy to Mounjaro often stems from cost considerations alongside clinical factors. At EverydayMeds (GPhC #9012878), we've observed that patients frequently compare the maintenance phase costs most carefully, as this represents their ongoing monthly commitment for sustained weight management. Wegovy's maintenance dose of £209.99 monthly provides predictable budgeting, whilst Mounjaro's pricing structure may appeal to different financial circumstances. Both prescription-only medicines require clinical assessment and ongoing prescriber monitoring, ensuring your transition between treatments remains safe and appropriate.
Wegovy Monthly Pricing Structure: Complete UK Cost Breakdown
Moving from Wegovy to Mounjaro requires understanding Wegovy's complete monthly cost journey first. The initial four months cost £79.99, £94.99, £99.99, and £139.99 respectively, totalling £414.96 for the dose escalation period. From month five onwards, patients pay £209.99 monthly for the 2.4mg maintenance dose. New customers benefit from our FIRST40 discount code applied at checkout, whilst returning customers use DOSE25 for continued savings. This transparent pricing structure allows patients to budget approximately £2,520 annually for maintenance-phase Wegovy treatment.
Our bundle options can provide additional convenience when moving from Wegovy to Mounjaro considerations. The Ultimate Stability Trio offers three months of maintenance 2.4mg supply for £649.99, ensuring treatment continuity without monthly reordering. The Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99, covering the first three months of treatment for new patients. These bundles prioritise convenience and Reliable Supply rather than cost savings, but they demonstrate our commitment to supporting patients throughout their weight management journey, whether continuing with Wegovy or transitioning to alternative treatments.
Clinical Evidence: Moving From Wegovy To Mounjaro Considerations
Patients moving from Wegovy to Mounjaro should understand the clinical foundation behind both treatments. In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved average weight loss of approximately 15% at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events among adults with established cardiovascular disease.
Mounjaro's clinical profile stems from the SURMOUNT trials, showing its dual GIP and GLP-1 receptor agonist mechanism. However, comparing trial results directly isn't appropriate due to different study designs, populations, and endpoints. Patients considering moving from Wegovy to Mounjaro should discuss their individual clinical response, tolerability, and treatment goals with their prescriber rather than relying solely on trial averages.
How Wegovy Works: Understanding Semaglutide's Mechanism
Before moving from Wegovy to Mounjaro, understanding how Wegovy works helps contextualise the potential benefits of staying with semaglutide treatment. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1. This hormone is naturally released after eating and signals feelings of fullness to the brain's appetite control centres. By activating GLP-1 receptors, Wegovy may help reduce appetite, increase satiety after smaller meals, and potentially diminish food cravings. The once-weekly injection provides sustained hormone activity, supporting consistent appetite regulation throughout the week. This mechanism works most effectively alongside a reduced-calorie diet and increased physical activity, as recommended in the UK prescribing guidelines.
EverydayMeds Ordering Process: Seamless Treatment Access
Whether continuing with Wegovy or moving from Wegovy to Mounjaro, our streamlined process ensures clinical safety and convenience. The journey begins with a comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight management goals, and any previous GLP-1 treatment experience. Our UK-registered prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring appropriate treatment selection. Once approved, your prescription-only medicine is dispatched via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transport. This process applies equally whether you're starting Wegovy or switching between treatments, with our clinical team providing guidance specific to your circumstances.
Storage and Practical Considerations When Moving From Wegovy To Mounjaro
Storage requirements differ between Wegovy and Mounjaro, which may influence your decision when moving from Wegovy to Mounjaro. Wegovy must be stored in the fridge at 2-8°C before first use, but offers significant travel flexibility with 6 weeks of room temperature storage (below 30°C) once removed from refrigeration. Mounjaro provides only 21 days at room temperature, making Wegovy more convenient for extended travel or irregular schedules. Both treatments use pre-filled injection pens, but Wegovy's FlexTouch pen system has been refined over many years of use. The dose escalation protocols also differ, with Wegovy following a structured 16-week progression to the 2.4mg maintenance dose, whilst Mounjaro uses its own escalation schedule.
Budget Planning: Annual Costs When Moving From Wegovy To Mounjaro
Long-term budget planning becomes crucial when moving from Wegovy to Mounjaro, as both treatments typically require ongoing use for sustained benefits. Wegovy's annual maintenance cost of approximately £2,520 (£209.99 × 12 months) provides predictable financial planning once you reach the 2.4mg dose. The initial escalation period adds £414.96 to first-year costs, totalling around £2,935 for year one. Our DOSE25 discount code for returning customers helps manage these ongoing expenses, ensuring consistent access to treatment.
Patients moving from Wegovy to Mounjaro often discover that cost predictability varies between treatments. Wegovy's established pricing structure at EverydayMeds means patients can accurately budget their monthly medication expenses, plan for annual healthcare costs, and understand the long-term financial commitment. This transparency proves particularly valuable for patients using healthcare savings accounts or budgeting for comprehensive weight management programmes including dietary support and exercise guidance.
Complete Treatment Support: Beyond Moving From Wegovy To Mounjaro
At EverydayMeds (GPhC #9012878), we recognise that moving from Wegovy to Mounjaro represents just one aspect of comprehensive weight management support. Our clinical team provides ongoing guidance throughout your treatment journey, whether you continue with semaglutide or transition to tirzepatide. Both Wegovy and Mounjaro are available through our platform, meaning you won't need to switch pharmacy providers when changing treatments. Your prescriber can help determine which option suits your clinical needs, budget considerations, and lifestyle requirements. Remember, both treatments work most effectively alongside a reduced-calorie diet and increased physical activity, supported by our comprehensive patient resources and clinical guidance. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today, using code FIRST40 for new customers or DOSE25 for returning patients seeking the most appropriate treatment for your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
